Delivery Order SPE2DR25D2101-SPE2DR26F46FE
Award Date 12/5/25
Potential Completion Date 12/8/25
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $27,740 delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/mL pens (3mL) with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order, awarded on September 26, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-competitive delivery order issued under an existing contract vehicle, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Insulin Aspart 100 Unit/mL pens (3mL) under a firm fixed-price contract with a ceiling value of $1,865.96. This non-set-aside delivery order is scheduled for completion by September 11, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,300.68 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL pens (3mL) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a non-set-aside, competitively awarded transaction and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.96 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/ML pens (3ML) with a firm fixed price structure. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and is not designated as a set-aside contract. This delivery order represents a competitive award exercised under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Insulin Aspart 100 Unit/mL pens (3mL) with a ceiling value of $3,523.33 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by December 11, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Insulin Aspart 100 Unit/mL pens (3mL) with a ceiling value of $54,186.47 under a firm fixed-price contract. This competitively awarded delivery order, with no set-aside designation, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems. The contract specifies performance at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $2,826.40 delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/ML pens (3ML) on June 17, 2025, with an ultimate completion date of June 18, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's significant $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Aspart 100 Unit/ML pen 3ML under a firm fixed price contract with a ceiling value of $4,145.26. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency has awarded a delivery order valued at $2,671.90 to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/ML in 10 ML vials. This firm fixed price delivery order, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The award is unset-aside and competitively awarded, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Insulin Aspart 100 Unit/ML pens (3ML) with a ceiling value of $9,672.58. This firm fixed price delivery order, which is not associated with a set-aside program, represents a competitive procurement to support federal medical supply needs. The order is scheduled for completion by August 14, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in...